Guardian Bio

Developer of cell-therapeutics for the treatment of cancer

placeBoston, Massachusetts, United States calendar_todayFounded 2022 groups3 employees language guardian-bio.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 2 times.

YearFilings
20251

Investor mix

3 investors on record; lead investors include Y Combinator.

Investor typeCountShare
Venture capital3100%
Coming soon